Dengue virus type 2 modulates endothelial barrier function through CD73

American Journal of Tropical Medicine and Hygiene

Volumn 88, Issue 1, 2013, Pages 89-94

  Patkar, Chinmay ^a   Giaya, Kris ^a   Libraty, Daniel H ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; GAMMA INTERFERON RECEPTOR 1; INTERFERON; RECOMBINANT BETA INTERFERON; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; RECOMBINANT VASCULOTROPIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DENGUE; DENGUE VIRUS 2; ENDOTHELIUM CELL; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HOMEOSTASIS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

5'-NUCLEOTIDASE; CELLS, CULTURED; DENGUE VIRUS; ENDOTHELIUM, VASCULAR; HUMANS;

DENGUE VIRUS TYPE 2;

EID: 84872310808     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2012.12-0474     Document Type: Article

References (27)

1. Initiative DV, 2012. Disease Burden. Available at: http://www. denguevaccines.org/disease-burden. Accessed May 7, 2012.
2. Henchal EA, Putnak JR, 1990. The dengue viruses. Clin Microbiol Rev 3: 376-396.
3. Dewi BE, Takasaki T, Kurane I, 2004. In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. J Virol Methods 121: 171-180. (Pubitemid 39295707)
4. Talavera D, Castillo AM, Dominguez MC, Gutierrez AE, Meza I, 2004. IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol 85: 1801-1813. (Pubitemid 39023258)
5. Jessie K, Fong MY, Devi S, Lam SK, Wong KT, 2004. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis 189: 1411-1418. (Pubitemid 38543590)
6. Gubler DJ, Zaki SR, 1998. Dengue and other viral hemorrhagic fevers. Nelson AM, Horsburgh CR Jr, eds. Pathology of Emerging Infections 2. Washington, DC: American Society for Microbiology Press, 43-67.
7. Rothman AL, 2011. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11: 532-543.
8. World Health Oganization, 1997. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control . Geneva: World Health Organization.
9. Rothman AL, Ennis FA, 1999. Immunopathogenesis of dengue hemorrhagic fever. Virology 257: 1-6. (Pubitemid 29391794)
10. Mehta D, Malik AB, 2006. Signaling mechanisms regulating endothelial permeability. Physiol Rev 86: 279-367.
11. Shasby DM, Roberts RL, 1987. Transendothelial transfer of macromolecules in vitro. Fed Proc 46: 2506-2510.
12. Deli MA, Abraham CS, Kataoka Y, Niwa M, 2005. Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell Mol Neurobiol 25: 59-127. (Pubitemid 40558585)
13. Luplertlop N, Misse D, Bray D, Deleuze V, Gonzalez JP, Leardkamolkarn V, Yssel H, Veas F, 2006. Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction. EMBO Rep 7: 1176-1181. (Pubitemid 44660576)
14. Libraty DH, Pichyangkul S, Ajariyakhajorn C, Endy TP, Ennis FA, 2001. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J Virol 75: 3501-3508. (Pubitemid 32246359)
15. Resta R, Yamashita Y, Thompson LF, 1998. Ecto-enzyme and signaling functions of lymphocyte CD73. Immunol Rev 161: 95-109.
16. Narravula S, Lennon PF, Mueller BU, Colgan SP, 2000. Regulation of endothelial CD73 by adenosine: paracrine pathway for enhanced endothelial barrier function. J Immunol 165: 5262-5268.
17. Liu P, Woda M, Ennis FA, Libraty DH, 2009. Dengue virus infection differentially regulates endothelial barrier function over time through type I interferon effects. J Infect Dis 200: 191-201.
18. Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, Garcia-Sastre A, Katze MG, Gale M Jr, 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 82: 335-345. (Pubitemid 350309149)
19. Munoz-Jordan JL, Laurent-Rolle M, Ashour J, Martinez-Sobrido L, Ashok M, Lipkin WI, Garcia-Sastre A, 2005. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 79: 8004-8013. (Pubitemid 40853504)
20. Rodriguez-Madoz JR, Belicha-Villanueva A, Bernal-Rubio D, Ashour J, Ayllon J, Fernandez-Sesma A, 2010. Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex. J Virol 84: 9760-9774.
21. Srikiatkhachorn A, Ajariyakhajorn C, Endy TP, Kalayanarooj S, Libraty DH, Green S, Ennis FA, Rothman AL, 2007. Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic fever. J Virol 81: 1592-1600. (Pubitemid 46214434)
22. Wang JP, Liu P, Latz E, Golenbock DT, Finberg RW, Libraty DH, 2006. Flavivirus activation of plasmacytoid dendritic cells delineates key elements of TLR7 signaling beyond endosomal recognition. J Immunol 177: 7114-7121. (Pubitemid 44715079)
23. Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, Lei HY, Lee CK, Chiou TW, Wong CH, Hsieh SL, 2008. CLEC5A is critical for dengue-virus-induced lethal disease. Nature 453: 672-676. (Pubitemid 351769308)
24. Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, Ennis FA, Rothman AL, Libraty DH, 2004. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis 189: 990-1000. (Pubitemid 38373090)
25. Nooteboom A, Hendriks T, Otteholler I, van der Linden CJ, 2000. Permeability characteristics of human endothelial monolayers seeded on different extracellular matrix proteins. Mediators Inflamm 9: 235-241. (Pubitemid 32055502)
26. Ribatti D, Nico B, Vacca A, Roncali L, Dammacco F, 2002. Endothelial cell heterogeneity and organ specificity. J Hematother Stem Cell Res 11: 81-90. (Pubitemid 34163772)
27. Renkonen J, Tynninen O, Hayry P, Paavonen T, Renkonen R, 2002. Glycosylation might provide endothelial zip codes for organ-specific leukocyte traffic into inflammatory sites. Am J Pathol 161: 543-550. (Pubitemid 36142163)